Abstract
Get full access to this article
View all access options for this article.
References
1.
Lenharo
M
. Brazil’s record dengue surge: why a vaccine campaign is unlikely to stop it . Nature 2024 ;627 :250 –251 . https://www.nature.com/articles/d41586-024-00626-3 (2024, accessed 3 April 2024) .
2.
Triunfol
M
. Brazil is hoping and waiting for a new vaccine as dengue rages . Science 2024 ; 383 : 1042 –1043 .
3.
Kallas
E
Cintra
M
Patino
E
, et al. Live, attenuated, tetravalent Butantan-Dengue vaccine in children and adults . N Engl J Med 2024 ; 390 : 397 –408 .
4.
Fatima
K
Syed
NI
. Dengvaxia controversy: impact on vaccine hesitancy . J Glob Health 2018 ; 8 : 8 –10 .
5.
Shukla
R
Ramasamy
V
Shanmugam
RK
, et al. Antibody-dependent enhancement: a challenge for developing a safe dengue vaccine . Front Cell Infect Microbiol 2020 ; 10 : 1 –12 .
6.
Williams
M
Mayer
SV
Johnson
WL
, et al. Lineage II of southeast Asian/American DENV-2 is associated with a severe dengue outbreak in the Peruvian Amazon . Am J Trop Med Hyg 2014 ; 91 : 611 –620 .